Administration in vivo of recombinant interleukin 2 protects mice against septic death.

Administration in vivo of recombinant interleukin 2 (rIL-2) to mice induces a polyclonal IgM response. When co-administered with a specific antigen, rIL-2 can enhance concentrations of murine IgM antibodies specific for the antigen by fivefold within 7 d of initial treatment. IgM antibodies that are...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Weyand, C, Goronzy, J, Fathman, C G, O'Hanley, P
Médium: Artigo
Jazyk:Inglês
Vydáno: 1987
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC424518/
https://ncbi.nlm.nih.gov/pubmed/3294901
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky